Auricular Acupuncture and Hot Flashes During Adjuvant Endocrine Therapy

Trial Title: Auricular Acupuncture and Hot Flashes During Adjuvant Endocrine Therapy

NCT ID: NCT06369168

Condition: Hot Flashes

Conditions: Official terms:
Hot Flashes

Conditions: Keywords:
breast cancer
hot flashes
acupuncture
endocrine therapy

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: randomized controlled trial

Primary purpose: Treatment

Masking: Single (Participant)

Intervention:

Intervention type: Device
Intervention name: auricular acupuncture
Description: two auricular acupuncture methods are compared with each other and with no treatment
Arm group label: NADA auricular acupuncture
Arm group label: balanced auricular acupuncture

Summary: With this clinical trial we investigate whether auricular acupuncture during adjuvant endocrine therapy has an improving effect on hot flashes, which are often perceived as psychologically and physically stressful in self-assessment of women with breast cancer. Empirical studies indicate that body acupuncture has positive effects on hot flashes. As auricular acupuncture offers a number of advantages over body acupuncture, a three-armed randomised controlled research design is being used to investigate whether hot flashes caused by endocrine therapy are also reduced by ear acupuncture. Balanced ear acupuncture will be compared with NADA ear acupuncture in terms of efficacy and effectiveness. In addition, the effects of the two forms of therapy on the patients' individual quality of life, fatigue, stress perception and sleep quality will be analysed.

Detailed description: In Germany, one in eight women will develop breast cancer in her lifetime, with a relative 5-year survival rate of 88%. Around 70 % of breast cancer cases are hormone receptor positive. Adjuvant endocrine therapy is recommended to reduce the risk of recurrence.The results of a systematic review show that around 52.4 % to 84.8 % of patients adhere to the treatment. It was also shown that non-adherence to treatment has a negative impact on the risk of breast cancer recurrence and the development of distant metastases, as well as on mortality. Lack of adherence to treatment is related, among other things, to the side effects of endocrine therapy, which significantly reduce quality of life. In particular, musculoskeletal syndrome and sleep disorders lead to discontinuation of endocrine treatment with an aromatase inhibitor. Many patients also suffer from hot flashes, sexual dysfunction, weight gain, bone density loss, depression, cognitive dysfunction and fatigue. The study focuses on hot flashes, which have a negative impact on sleep and promote symptoms of fatigue. Due to the endocrine therapy, the symptoms are usually more pronounced than the menopause-related symptoms. However, oestrogen-based hormone replacement therapy is contraindicated, while non-hormonal medication such as venlafaxine or gabapentin often have serious side effects. An alternative is body acupuncture, which can decrease hot flashes in women with breast cancer. One of the advantages of acupuncture compared to drug treatments is that it is considered having very few side effects. With the help of a three-armed randomized controlled research design, this study aims to investigate the efficacy and effectiveness of balanced ear acupuncture compared to NADA ear acupuncture in the treatment of hot flashes caused by endocrine therapy. In addition, the effects of the two forms of therapy on the individual quality of life, fatigue, stress perception and sleep quality of the patients will be analyzed.The respective results will be compared with those of a control group that did not receive acupuncture during the observation period.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - histologically confirmed diagnosis of non-metastatic hormone receptor-positive breast CA (TNM stage I-III) under adjuvant endocrine therapy - hot flashes, measured with the MRS (Menopause Rating Scale) - willingness to participate in the study and signed informed consent Exclusion Criteria: - ongoing or planned chemotherapy, radiotherapy, follow-up treatment or reconstructive plastic surgery during the study period - severe physical or psychopharmacologically treated psychiatric comorbidity, due to which a patient is unable to participate in the study - pregnancy - participation in other clinical trials with behavioural, psychological or complementary medicine, psychological or complementary medical interventions - regular use of barbiturates, antidepressants, abuse of drugs and/or alcohol - ongoing acupuncture treatment - lack of ability to complete the questionnaires independently - operations or infections in the area to be acupunctured

Gender: Female

Gender based: Yes

Minimum age: 18 Years

Maximum age: 75 Years

Healthy volunteers: No

Locations:

Facility:
Name: Evang. Kliniken Essen-Mitte gGmbH

Address:
City: Essen
Zip: Essen
Country: Germany

Status: Recruiting

Facility:
Name: Evang. Kliniken Essen-Mitte gGmbH

Address:
City: Essen
Country: Germany

Status: Recruiting

Start date: June 17, 2024

Completion date: November 20, 2025

Lead sponsor:
Agency: Kliniken Essen-Mitte
Agency class: Other

Collaborator:
Agency: Karl and Veronica Carstens Foundation
Agency class: Other

Source: Kliniken Essen-Mitte

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06369168